Cargando…
PReS-FINAL-2090: Efficacy of anti-TNF drugs from the perspective of growth velocity: a single center experience
Autores principales: | Mrážik, P, Vargová, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042626/ http://dx.doi.org/10.1186/1546-0096-11-S2-P102 |
Ejemplares similares
-
Efficacy of TNF blockers from the perspective of growth velocity: slovak experience
por: Mrážik, Pavol, et al.
Publicado: (2014) -
PReS-FINAL-2314: Anti-TNF alpha therapy for refractory childhood takayasu arthritis
por: Koren, B, et al.
Publicado: (2013) -
PReS-FINAL-2265: Tuberculosis in pediatric patients who are receiving anti-TNF agents
por: Calzada-Hernández, J, et al.
Publicado: (2013) -
PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha
por: Christensen, AE, et al.
Publicado: (2013) -
PReS-FINAL-2064: Effect of Goloimumab a new anti-TNF, in patients with the diagnosis of juvenile idiopathic arthritis
por: Kienast, A, et al.
Publicado: (2013)